Advertisement

Digestive Diseases and Sciences

, Volume 58, Issue 8, pp 2138–2147 | Cite as

A Systematic Review of SAPHO Syndrome and Inflammatory Bowel Disease Association

  • Juan E. Naves
  • Eduard Cabré
  • Míriam Mañosa
  • Dolors Grados
  • Alejandro Olivé
  • Eugeni Domènech
Review

Abstract

Background

The association between inflammatory bowel disease (IBD) and synovitis, acne, pustulosis, hyperostosis, osteitis syndrome (SAPHO syndrome) was first reported in 1992. To date, only case reports and short series have been published.

Aims

The purpose of this study was to report new cases and systematically review the literature on this association.

Materials and Methods

All patients with concomitant diagnosis of SAPHO syndrome and IBD were identified from the databases of the rheumatology and gastroenterology departments of our institution. In addition, we systematically searched for published full articles in Medlars Online International Literature via PubMed. Relevant information of each positive match was collected and all authors were contacted for additional clinical data.

Results

Three patients sharing both SAPHO syndrome and IBD were identified among the 62 patients with SAPHO syndrome (4.8 % of the SAPHO cohort) and the 1,309 patients with IBD (0.2 % of the IBD cohort) from our hospital database. After a systematic review, a total of 39 reported patients with concomitant diagnosis of SAPHO syndrome and IBD were identified. There was a female predominance and most had Crohn’s disease with colonic involvement.

Conclusions

The association of SAPHO syndrome and IBD seems to be rare among IBD patients but not so among SAPHO patients. SAPHO could be underdiagnosed because of the similarity of its clinical manifestations and some more common extraintestinal manifestations or drug-related side effects in IBD.

Keywords

Inflammatory bowel disease Ulcerative colitis Crohn’s disease SAPHO syndrome Chronic recurrent multifocal osteomyelitis 

Notes

Acknowledgments

The authors want to thank Dr. Marcel F. Kahn, Dr. Keyhan Sayadpour, Dr. Carlo M. Girelli, Dr. Osamu Yamasaki, Dr. Athos Bousvaros, Dr. Craig Friesen, Dr. Henner Morbach, and Dr. Elaine Siegfried for their kind collaboration in providing additional data on their patients.

Conflict of interest

None.

References

  1. 1.
    Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122.PubMedCrossRefGoogle Scholar
  2. 2.
    Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;14:7227–7236.Google Scholar
  3. 3.
    Bonapace ES, Srinivasan R. Simultaneous occurrence of inflammatory bowel disease and thyroid disease. Am J Gastroenterol. 2001;96:1925–1926.PubMedCrossRefGoogle Scholar
  4. 4.
    Shah SA, Peppercorn MA, Pallotta JA. Autoimmune (Hashimoto’s) thyroiditis associated with Crohn’s disease. J Clin Gastroenterol. 1998;26:117–120.PubMedCrossRefGoogle Scholar
  5. 5.
    Curtis WD, Schuman BM, Griffin JW Jr. Association of gluten-sensitive enteropathy and Crohn’s colitis. Am J Gastroenterol. 1992;87:1634–1637.PubMedGoogle Scholar
  6. 6.
    Malmusi M, Manca V, Girolomoni G. Coexistence of dermatitis herpetiformis, gluten-sensitive enteropathy, and ulcerative colitis. J Am Acad Dermatol. 1994;31:1050–1051.PubMedCrossRefGoogle Scholar
  7. 7.
    Kimura K, Hunter SF, Thollander MS, et al. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clin Proc. 2000;75:802–806.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn’s disease and their relatives. Am J Gastroenterol. 1990;85:962–963.PubMedGoogle Scholar
  9. 9.
    Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey 85 cases. Rev Rhum Mal Osteoartic. 1987;54:187–196.PubMedGoogle Scholar
  10. 10.
    Giedon A, Holthusen W, Masel LF, et al. Subacute an chronic symmetrical osteomyelitis. Ann Radiol. 1972;15:329–342.Google Scholar
  11. 11.
    Sonozaki H, Kawashima M, Hongo O, et al. Incidence of arthro-osteitis in patients with pustulosis palmaris et plantaris. Ann Rheum Dis. 1981;40:554–557.PubMedCrossRefGoogle Scholar
  12. 12.
    Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin Rheumatol. 1994;8:333–362.PubMedCrossRefGoogle Scholar
  13. 13.
    Benhamou CL, Chamot AM, Kahn MF. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol. 1988;6:109–112.PubMedGoogle Scholar
  14. 14.
    Boutin RD, Resnick D. The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. AJR Am J Roentgenol. 1998;170:585–591.PubMedCrossRefGoogle Scholar
  15. 15.
    Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum. 2012;42:254–265.PubMedCrossRefGoogle Scholar
  16. 16.
    Darley CR, Currey HL, Baker H. Acne fulminans with arthritis in identical twins treated with isotretinoin. J R Soc Med. 1984;77:328–330.PubMedGoogle Scholar
  17. 17.
    González T, Gantes M, Bustabad S, et al. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol. 1985;12:389–391.PubMedGoogle Scholar
  18. 18.
    Ferguson PJ, Bing X, Vasef MA, et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone. 2006;38:41–47.PubMedCrossRefGoogle Scholar
  19. 19.
    Yeon HB, Lindor NM, Seidman JG, et al. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet. 2000;66:1443–1448.PubMedCrossRefGoogle Scholar
  20. 20.
    Majeed HA, Kalaawi M, Mohanty D, et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr. 1989;115:730–734.PubMedCrossRefGoogle Scholar
  21. 21.
    Kotilainen P, Merilahti-Palo R, Lehtonen OP, et al. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol. 1996;23:1302–1304.PubMedGoogle Scholar
  22. 22.
    Schaeverbeke T, Lequen L, de Barbeyrac B, et al. Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis. Arthritis Rheum. 1998;41:1889–1893.PubMedCrossRefGoogle Scholar
  23. 23.
    Wagner AD, Andresen J, Jendro MC, et al. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. 2002;46:1965–1968.PubMedCrossRefGoogle Scholar
  24. 24.
    Olivieri I, Padula A, Ciancio G, et al. Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis. 2002;61:375–376.PubMedCrossRefGoogle Scholar
  25. 25.
    Steinhoff JP, Cilursu A, Falasca GF, et al. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol. 2002;8:13–22.PubMedCrossRefGoogle Scholar
  26. 26.
    Kahn MF, Bouchon JP, Chamot AM, et al. Chronic enterocolopathies and SAPHO syndrome. 8 cases. Rev Rhum Mal Osteoartic. 1992;59:91–94.PubMedGoogle Scholar
  27. 27.
    Manners P, Robbins P. Chronic recurrent multifocal osteomyelitis with Crohn’s disease exacerbation and vasculitis after granulocyte colony-stimulating factor therapy. J Clin Rheumatol. 2000;6:283–290.PubMedCrossRefGoogle Scholar
  28. 28.
    Colina M, Govoni M, Orzincolo C, et al. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum. 2009;15:813–821.CrossRefGoogle Scholar
  29. 29.
    Hayem G, Bouchaud-Chabot A, Benali K, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum. 1999;29:159–171.PubMedCrossRefGoogle Scholar
  30. 30.
    Kotilainen PM, Laxen FO, Manner IK, et al. An aseptic inflammation of the clavicle in a patient with Crohn’s disease. A potential manifestation of the SAPHO syndrome. Scand J Rheumatol. 1996;25:112–114.PubMedCrossRefGoogle Scholar
  31. 31.
    Sanjuán Portugal F, Nerín Sánchez C, Fuentes Solsona F, et al. The SAPHO syndrome and ulcerative colitis. An Med Inter. 1997;14:210–211.Google Scholar
  32. 32.
    Dharancy S, Talbodec N, Asselah T, et al. The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn’s disease. Presentation of 1 case and review of the literature. Gastroenterol Clin Biol. 1998;22:240–243.PubMedGoogle Scholar
  33. 33.
    Omidi CJ, Siegfried EC. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient. Pediatr Dermatol. 1998;15:435–438.PubMedCrossRefGoogle Scholar
  34. 34.
    Bognar M, Blake W, Agudelo C. Chronic recurrent multifocal osteomyelitis associated with Crohn’s disease. Am J Med Sci. 1998;315:133–135.PubMedCrossRefGoogle Scholar
  35. 35.
    Murata I, Satoh K, Yoshikawa I, et al. Recurrent subcutaneous abscess of the sternal region in ulcerative colitis. Am J Gastroenterol. 1999;94:844–845.PubMedCrossRefGoogle Scholar
  36. 36.
    Bousvaros A, Marcon M, Treem W, et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44:2500–2507.PubMedCrossRefGoogle Scholar
  37. 37.
    Bazrafshan A, Zanjani KS. Chronic recurrent multifocal osteomyelitis associated with ulcerative colitis: a case report. J Pediatr Surg. 2000;35:1520–1522.PubMedCrossRefGoogle Scholar
  38. 38.
    Girelli CM, Scarpellini M. Gastric Crohn’s disease and SAPHO syndrome. Clin Exp Rheumatol. 2001;19:356.PubMedGoogle Scholar
  39. 39.
    Yamasaki O, Iwatsuki K, Kaneko F. A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Behçet’s disease. Adv Exp Med Biol. 2003;528:339–341.PubMedCrossRefGoogle Scholar
  40. 40.
    Schilling F, Märker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO. Z Rheumatol. 2003;62:527–538.PubMedCrossRefGoogle Scholar
  41. 41.
    Carpenter E, Jackson MA, Friesen CA, et al. Crohn’s-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144:541–544.PubMedCrossRefGoogle Scholar
  42. 42.
    Van Den Eynde M, Lecluyse K, Chioccioli C, et al. Crohn’s disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature. Gastroenterol Clin Biol. 2007;31:607–610.CrossRefGoogle Scholar
  43. 43.
    Skoura E, Giannopoulou C, Zaromytidou E, et al. A case of non-malignant multifocal lesions on the methyl diphosphonate technetium-99 m bone scan with enteropathy. SAPHO syndrome. Hell J Nucl Med. 2007;10:26–28.PubMedGoogle Scholar
  44. 44.
    Siau K, Laversuch CJ. SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate. Joint Bone Spine. 2010;77:176–177.PubMedCrossRefGoogle Scholar
  45. 45.
    Morbach H, Dick A, Beck C, et al. Association of chronic non-bacterial osteomyelitis with Crohn’s disease but not with CARD15 gene variants. Rheumatol Int. 2010;30:617–621.PubMedCrossRefGoogle Scholar
  46. 46.
    Schilling F. Chronic recurrent multifocal osteomyelitis (CRMO). Rofo. 1998;168:115–127.PubMedCrossRefGoogle Scholar
  47. 47.
    Beretta-Piccoli BC, Sauvain MJ, Gal I, et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr. 2000;159:594–601.PubMedCrossRefGoogle Scholar
  48. 48.
    Hayem G. Valuable lessons from SAPHO syndrome. Joint Bone Spine. 2007;74:123–126.PubMedCrossRefGoogle Scholar
  49. 49.
    Sallés M, Olivé A, Pérez-Andrés R, et al. The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol. 2011;30:245–249.PubMedCrossRefGoogle Scholar
  50. 50.
    Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.PubMedCrossRefGoogle Scholar
  51. 51.
    Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996;39:690–697.PubMedCrossRefGoogle Scholar
  52. 52.
    Wada R, Kawamura C, Inoue S, et al. Granulomatous colitis associated with botryomycosis of Propionibacterium acnes. Arch Pathol Lab Med. 2001;125:1491–1493.PubMedGoogle Scholar
  53. 53.
    Claudepierre P, Clerc D, Cariou D, et al. SAPHO syndrome and pyoderma gangrenosum: is it fortuitous? J Rheumatol. 1996;23:400–402.PubMedGoogle Scholar
  54. 54.
    Fournié B, Boutes A, Dromer C, et al. Prospective study of anterior chest wall involvement in ankylosing spondylitis and psoriatic arthritis. Rev Rheum Engl. 1997;64:22–25.Google Scholar
  55. 55.
    Delaporte E. Psoriasis and inflammatory bowel disease. Ann Dermatol Venereol. 2012;139:S46–S52.PubMedCrossRefGoogle Scholar
  56. 56.
    Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9:1–14.PubMedCrossRefGoogle Scholar
  57. 57.
    Guerra I, Algaba A, Pérez-Calle JL, et al. Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases. J Crohns Colitis. 2012;6:518–523.PubMedCrossRefGoogle Scholar
  58. 58.
    Klingenstein G, Levy RN, Kornbluth A, et al. Inflammatory bowel disease related osteonecrosis: report of a large series with review of the literature. Aliment Pharmacol Ther. 2005;21:243–249.PubMedCrossRefGoogle Scholar
  59. 59.
    Alhusayen RO, Juurlink DN, Mamdani MM, et al. Isotretinoin use and risk of inflammatory bowel disease. A population-based cohort study. J Invest Dermatol 2013;133:907–912. doi: 10.1038/jid.2012.387.Google Scholar
  60. 60.
    Assmann G, Kueck O, Kirchhoff T, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther. 2009;11:R140.PubMedCrossRefGoogle Scholar
  61. 61.
    Guignard S, Job-Deslandre C, Sayag-Boukris V, et al. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine. 2002;69:392–396.PubMedCrossRefGoogle Scholar
  62. 62.
    Amital H, Applbaum YH, Aamar S, et al. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford). 2004;43:658–661.CrossRefGoogle Scholar
  63. 63.
    Olivieri I, Padula A, Palazzi C. Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs. 2006;15:1229–1233.PubMedCrossRefGoogle Scholar
  64. 64.
    Ben Abdelghani K, Dran DG, Gottenberg JE, et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol. 2010;37:1699–1704.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Juan E. Naves
    • 1
  • Eduard Cabré
    • 1
    • 3
  • Míriam Mañosa
    • 1
    • 3
  • Dolors Grados
    • 2
  • Alejandro Olivé
    • 2
  • Eugeni Domènech
    • 1
    • 3
  1. 1.Department of GastroenterologyHospital Universitari Germans Trias i PujolBadalona, CataloniaSpain
  2. 2.Department of RheumatologyHospital Universitari Germans Trias i PujolBadalona, CataloniaSpain
  3. 3.Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)BarcelonaSpain

Personalised recommendations